Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Hanover - Delayed Quote EUR

Biomarin Pharmaceutical Inc (BM8.HA)

Compare
66.86
-0.02
(-0.03%)
At close: March 10 at 5:25:16 PM GMT+1
Loading Chart for BM8.HA
  • Previous Close 66.88
  • Open 0.00
  • Bid 66.36 x --
  • Ask 66.66 x --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 87.28
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 22, 2025 - Apr 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BM8.HA

View More

Performance Overview: BM8.HA

Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

BM8.HA
4.66%
S&P 500
4.54%

1-Year Return

BM8.HA
14.46%
S&P 500
9.58%

3-Year Return

BM8.HA
5.75%
S&P 500
31.81%

5-Year Return

BM8.HA
1.61%
S&P 500
94.80%

Compare To: BM8.HA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BM8.HA

View More

Valuation Measures

Annual
As of 3/7/2025
  • Market Cap

    12.65B

  • Enterprise Value

    12.16B

  • Trailing P/E

    32.64

  • Forward P/E

    18.05

  • PEG Ratio (5yr expected)

    0.49

  • Price/Sales (ttm)

    4.97

  • Price/Book (mrq)

    2.43

  • Enterprise Value/Revenue

    4.64

  • Enterprise Value/EBITDA

    20.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BM8.HA

View More

Company Insights: BM8.HA

Research Reports: BM8.HA

View More